RSH 4.76% 4.0¢ respiri limited

Respiri investor Presentation, page-46

  1. 27,395 Posts.
    lightbulb Created with Sketch. 1781
    I sent an email to [email protected] but haven't heard back.....maybe you can ask them for me?

    "Can you clarify whether the clinical data used to obtain CE and TGA approval was tested against just the stethoscope and not using the current clinician standard of spirometry, etc for measuring asthma and were the clinical data submit for FDA approval tested against just the stethoscope?"
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.